ライフサイエンスコーパス: hematopoietic progenitor cell

1 ells of the myeloid lineage, such as CD34(+) hematopoietic progenitor cells.

2 cells, eliminating the numbers of malignant hematopoietic progenitor cells.

3 and contribute to increased proliferation of hematopoietic progenitor cells.

4 ell as a twofold expansion of CD34(+)CD45(+) hematopoietic progenitor cells.

5 e HSC/MPP pools and promote clonogenicity of hematopoietic progenitor cells.

6 ctivation strongly enhances proliferation of hematopoietic progenitor cells.

7 as with enforced Erg expression in engrafted hematopoietic progenitor cells.

8 ating immune cells and PTH actions on marrow hematopoietic progenitor cells.

9 corrects the phenotype of in vitro cultured hematopoietic progenitor cells.

10 differentiation and self-renewal of CD34(+) hematopoietic progenitor cells.

11 hanism in the PTH-induced increase in marrow hematopoietic progenitor cells.

12 elial progenitor cells and CD34(+)/VEGFR1(+) hematopoietic progenitor cells.

13 nhancers marked with H3K4 monomethylation in hematopoietic progenitor cells.

14 regulates these processes in lymphocytes and hematopoietic progenitor cells.

15 of B-lymphoid cells from fetal liver-derived hematopoietic progenitor cells.

16 erted minimal toxicity toward normal CD34(+) hematopoietic progenitor cells.

17 est the repopulation potentials of candidate hematopoietic progenitor cells.

18 mote proliferative responses in normal human hematopoietic progenitor cells.

19 fficient to increase NK cell production from hematopoietic progenitor cells.

20 Z1) or placebo delivered in autologous CD34+ hematopoietic progenitor cells.

21 obin locus in human cells, including primary hematopoietic progenitor cells.

22 IR), suggesting that this steroid may act on hematopoietic progenitor cells.

23 onstrated significant loss of intestinal and hematopoietic progenitor cells.

24 al skeletal defects and increased numbers of hematopoietic progenitor cells.

25 cycling status of immature, but not mature, hematopoietic progenitor cells.

26 t increased the number of colonies formed by hematopoietic progenitor cells.

27 on, FGF2 compromises stromal cell support of hematopoietic progenitor cells.

28 function and apoptosis of AML but not normal hematopoietic progenitor cells.

29 tor of stromal cell supportive functions for hematopoietic progenitor cells.

30 ances both proliferation and self-renewal of hematopoietic progenitor cells.

31 ccount for the phenotypes displayed in human hematopoietic progenitor cells.

32 een apoptosis and senescence in reoxygenated hematopoietic progenitor cells.

33 ia-then-reoxygenation represent a stress for hematopoietic progenitor cells.

34 id-healing phenotype is not intrinsic to MRL hematopoietic progenitor cells.

35 kemia (AML) cells while not affecting normal hematopoietic progenitor cells.

36 ochondria compared with nonmalignant CD34(+) hematopoietic progenitor cells.

37 n functions to promote a latent state within hematopoietic progenitor cells.

38 en human CML were cultured with normal human hematopoietic progenitor cells.

39 activated in AML cells compared with normal hematopoietic progenitor cells.

40 ), Ly6C(high) myeloid cells from bone marrow hematopoietic progenitor cells.

41 n led to gain of replating capacity of mouse hematopoietic progenitor cells.

42 the differentiation process of iPSCs toward hematopoietic progenitor cells.

43 est that these tumors may arise instead from hematopoietic progenitor cells.

44 iminated the total number of JAKV617F(+) MPN hematopoietic progenitor cells.

45 g is critical for the self-renewal of normal hematopoietic progenitor cells.

46 B-cell neoplasm by inducing tumorigenesis in hematopoietic progenitor cells.

47 d STAT5 on LEF-1 expression and functions in hematopoietic progenitor cells.

48 n, as it affects the differentiation of most hematopoietic progenitor cells.

49 ll cycle arrest in HSCs and profound loss of hematopoietic progenitor cells.

50 redundant and kinase-dependent functions in hematopoietic progenitor cells.

51 h functions as a growth factor for primitive hematopoietic progenitor cells.

52 he levels of ESL-1 were strongly elevated in hematopoietic progenitor cells.

53 ith significantly increased numbers of HSCs, hematopoietic progenitor cell-1 (HPC-1), HPC-2, and Lin(

54 o yield CD8 alphabeta TCR-bearing cells from hematopoietic progenitor cells, a comprehensive and func

55 both recipient and donor Tregs can influence hematopoietic progenitor cell activity after transplanta

56 ly in the erythroid lineage in primary human hematopoietic progenitor cells after expression of shRNA

57 Thus, hematopoietic progenitor cell and cardiomyocyte fusion i

58 -deficient mice engrafted with human CD34(+) hematopoietic progenitor cells and autologous T cells.

59 ed for LC differentiation from human CD34(+) hematopoietic progenitor cells and blood monocytes in vi

60 potent antigen-presenting cells derived from hematopoietic progenitor cells and circulating monocytes

61 e development of human NK cells from CD34(+) hematopoietic progenitor cells and IFN-gamma production

62 Transduction of primary human CD34+ hematopoietic progenitor cells and immature dendritic ce

63 iferation and appropriate differentiation of hematopoietic progenitor cells and in animal hematopoies

64 associated with higher proliferation rate of hematopoietic progenitor cells and increased cells in ac

65 tein that confers self-renewal capability to hematopoietic progenitor cells and induces acute myeloge

66 r results show that STAT3 deficiency renders hematopoietic progenitor cells and myeloid precursors re

67 ga-dose" of T cell-depleted peripheral blood hematopoietic progenitor cells and no posttransplant pha

68 kidney transplants and an injection of CD34+ hematopoietic progenitor cells and T cells from HLA-matc

69 adiation, followed by the transplantation of hematopoietic progenitor cells and T cells from syngenei

70 the mammalian stress response gene SIRT1 in hematopoietic progenitor cells and that this involves ST

71 the effects of Hedgehog signaling within the hematopoietic progenitor cells and the magnitude of the

72 patient can be induced to differentiate into hematopoietic progenitor cells and then further to eryth

73 ired for latency and reactivation in CD34(+) hematopoietic progenitor cells and virion maturation in

74 Herein we show the expression of polySia on hematopoietic progenitor cells, and demonstrate a role f

75 thma, decreased B-lymphocyte development and hematopoietic progenitor cells, and lymphoid organ hypop

76 , but is absent on normal tissues, including hematopoietic progenitor cells, and may therefore be an

77 ndogenously expressed by a mast cell line or hematopoietic progenitor cells, and specifically blocks

78 n, intermediate reactivity toward monocytes, hematopoietic progenitor cells, and T-cells was observed

79 is detected in hematopoietic stem cells and hematopoietic progenitor cells, and that its expression

80 The findings indicate that Th2-promoting hematopoietic progenitor cells are rapidly recruited to

81 Hematopoietic progenitor cells are the progeny of hemato

82 actors (MIP-1alpha and IFNgamma) to which FA hematopoietic progenitor cells are uniquely vulnerable,

83 Using hematopoietic progenitors cells as a model, we demonstra

84 orrelate with the transcriptional program of hematopoietic progenitor cells, as well as of the erythr

85 wth factor A (Vegf-a)-dependent apoptosis of hematopoietic progenitor cells associated with overprodu

86 is not intrinsic to defects at the level of hematopoietic progenitor cells but is associated with a

87 ral killer (NK) cells originate from CD34(+) hematopoietic progenitor cells, but the discrete stages

88 ctivity, and transformation of Frat knockout hematopoietic progenitor cells by MLL fusions results in

89 opoiesis and changes in pre-mRNA splicing in hematopoietic progenitor cells by whole transcriptome an

90 The data suggest that hematopoietic progenitor cells can be genetically modifi

91 The abrogation of hematopoietic progenitor cells can be partially rescued

92 In hematopoietic progenitor cells, CD164 forms complexes wi

93 atic inoculation of human cord blood-derived hematopoietic progenitor cells (CD34(+)).

94 They, together with hematopoietic progenitor cells (collectively known as HS

95 linical aphereses while expanding the normal hematopoietic progenitor cell compartment.

96 Recent studies have found that peripheral hematopoietic progenitor cells contribute to type 2 cyto

97 ing endothelial cells (CECs) and circulating hematopoietic progenitor cells (CPCs) represent two cell

98 n lymphoid progenitors, pre-pro-B cells, and hematopoietic progenitor cells (day 12 spleen colony-for

99 Choice of a T lymphoid fate by hematopoietic progenitor cells depends on sustained Notc

100 Hematopoietic progenitor cells derived from human embryo

101 Both CD34+ hematopoietic progenitor cell-derived and CD14+ monocyte

102 , we have identified a role for B-Raf during hematopoietic progenitor cell development and during meg

103 mice treated with G-CSF for mobilization of hematopoietic progenitor cells display reduced levels of

104 fies frequencies of growth-factor responsive hematopoietic progenitor cells during steady state and a

105 n attenuated strain of CMV are maintained in hematopoietic progenitor cells during their differentiat

106 The mechanisms of hematopoietic progenitor cell egress and clinical mobili

107 combined with Peg IFN-alpha 2a can target PV hematopoietic progenitor cells, eliminating the numbers

108 reviously shown that HCMV infection of human hematopoietic progenitor cells engrafted in immune defic

109 Culture of hematopoietic progenitor cells ex vivo reveals that surf

110 factor in articular joints, is implicated in hematopoietic progenitor cell expansion and megakaryopoi

111 Given that human hematopoietic progenitor cells express many of the known

112 Furthermore, Gata3 mutant hematopoietic progenitor cells fail to be recruited into

113 ) in acute myeloid leukemia, is required for hematopoietic progenitor cell fate decisions and for ear

114 We next analyzed the fetal hematopoietic progenitor cells for changes in reactive o

115 tropenias and for mobilization of peripheral hematopoietic progenitor cells for stem cell transplanta

116 otein 4, PGE2, and SR1 led to robust Mn iPSC hematopoietic progenitor cell formation.

117 sion and associated ERK1/2 activation during hematopoietic progenitor cell formation.

118 ultured from peripheral blood or bone marrow hematopoietic progenitor cells from four patients were u

119 iptional repressor Slug specifically rescues hematopoietic progenitor cells from lethal doses of gamm

120 ce-activated cell sorting (FACS) of c-kit(+) hematopoietic progenitor cells from mixed bone marrow po

121 BM) chimeras were generated by transplanting hematopoietic progenitor cells from stress-susceptible m

122 creased rDNA promoter methylation in CD34(+) hematopoietic progenitor cells from the majority of MDS

123 These features prevented hematopoietic progenitor cells from transmigrating into

124 ranscription factor GATA-2 is vital for both hematopoietic progenitor cell function and urogenital pa

125 Additionally, AP23464 did not disrupt normal hematopoietic progenitor-cell growth at concentrations t

126 Expression-based studies of multipotential hematopoietic progenitor cells has shown that these cell

127 addition to resting CD4(+) T cells, CD34(+) hematopoietic progenitor cells have been proposed as ano

128 rect association between HIV-1 infection and hematopoietic progenitor cell health in Botswana.

129 vestigate the downstream targets of HOXB4 in hematopoietic progenitor cells, HOXB4 was constitutively

130 t3 ligand to conditionally immortalize early hematopoietic progenitor cells (Hoxb8-FL cells).

131 ow that leukemic cell growth disrupts normal hematopoietic progenitor cell (HPC) bone marrow niches a

132 factors that regulate murine ES cell-derived hematopoietic progenitor cell (HPC) commitment to the B

133 ony-forming cells belong to the conventional hematopoietic progenitor cell (HPC) compartment.

134 ly identified T cell-dependent regulation of hematopoietic progenitor cell (HPC) numbers and cycling.

135 -derived cells to the circulating definitive hematopoietic progenitor cell (HPC) pool that seeds the

136 ulation of hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) proliferation, survi

137 The increased use of hematopoietic progenitor cell (HPC) transplantation has

138 mice have greatly reduced numbers of cycling hematopoietic progenitor cells (HPC) in the BM and great

139 report that inhibition of Notch signaling in hematopoietic progenitor cells (HPC), myeloid-derived su

140 T-cell populations that recognized aneuploid hematopoietic progenitor cells (HPC).

141 of total cells, CD34(+) cells, and assayable hematopoietic progenitor cells (HPC).

142 a major factor mediating interaction between hematopoietic progenitor cells (HPCs) and bone marrow st

143 effects of these molecules on huCB and muBM hematopoietic progenitor cells (HPCs) and HSCs.

144 We explored p67 expression on normal hematopoietic progenitor cells (HPCs) and its putative r

145 ased bone marrow (BM) function and shifts in hematopoietic progenitor cells (HPCs) and lineage-commit

146 xpression of RUNX1a facilitates emergence of hematopoietic progenitor cells (HPCs) and positively reg

147 e, CCR2 was expressed on subsets of HSCs and hematopoietic progenitor cells (HPCs) and that freshly i

148 sis, we examined whether HIV-1C could infect hematopoietic progenitor cells (HPCs) and whether this p

149 Hematopoietic progenitor cells (HPCs) are central to hem

150 Within the bone marrow (BM), hematopoietic progenitor cells (HPCs) are localized in p

151 Adult hematopoietic progenitor cells (HPCs) are maintained by

152 oiesis characterized by increased numbers of hematopoietic progenitor cells (HPCs) at the expense of

153 but it has recently been shown that CD34(+) hematopoietic progenitor cells (HPCs) can also become la

154 hierarchy among intermediate populations of hematopoietic progenitor cells (HPCs) derived from human

155 In this study, we demonstrate that hematopoietic progenitor cells (HPCs) derived from mouse

156 Mouse BM hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) express CD1d.

157 fety and effectiveness of mobilizing CD34(+) hematopoietic progenitor cells (HPCs) in adults with bet

158 Hematopoietic progenitor cells (HPCs) in the bone marrow

159 nction in promoting viral latency in CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro,

160 In CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro,

161 ) in promoting a latent infection in CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro.

162 nocytes and mouse peritoneal macrophages and hematopoietic progenitor cells (HPCs) into myeloid DCs.

163 d CD34(+)CXCR4(+) cells as well as assayable hematopoietic progenitor cells (HPCs) irrespective of th

164 ation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) is crucial for cor

165 entiation of embryonic stem cells (ESC) into hematopoietic progenitor cells (HPCs) is crucial for the

166 Here we show that deletion of Rhoh in hematopoietic progenitor cells (HPCs) leads to increased

167 rus (HCMV) can establish latent infection in hematopoietic progenitor cells (HPCs) or CD14 (+) monocy

168 strate that activation of Notch signaling in hematopoietic progenitor cells (HPCs) promoted different

169 However, a specific role for ADAR1 in adult hematopoietic progenitor cells (HPCs) remains elusive.

170 in mediates the enhanced survival of primary hematopoietic progenitor cells (HPCs) resulting from ITD

171 a homeobox transcription factor, to generate hematopoietic progenitor cells (HPCs) that successfully

172 resulted in a reduction in the proportion of hematopoietic progenitor cells (HPCs) that were JAK2V617

173 To determine susceptibility of human CD34+ hematopoietic progenitor cells (HPCs) to infection with

174 Hematopoietic progenitor cells (HPCs) traffic to and are

175 (HSCs), impaired radioprotective function of hematopoietic progenitor cells (HPCs), and myeloid and e

176 determine the effect of fibrosis on healthy hematopoietic progenitor cells (HPCs), bioartificial mat

177 t5 deletion resulted in a concurrent loss of hematopoietic progenitor cells (HPCs), leading to fatal

178 le entry of hematopoietic stem cells (HSCs)/ hematopoietic progenitor cells (HPCs), leading to their

179 In a cell line model of mouse hematopoietic progenitor cells (HPCs), we found enhanced

180 d lung homing of bone marrow-derived CD34(+) hematopoietic progenitor cells (HPCs), which include eos

181 c stem cells (HSCs) generate highly dividing hematopoietic progenitor cells (HPCs), which produce all

182 fted with human umbilical cord blood CD34(+) hematopoietic progenitor cells (HPCs).

183 e marrow hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

184 tor of CXCR4 expression in human CB HSCs and hematopoietic progenitor cells (HPCs).

185 infection and killing of CD34(+) multipotent hematopoietic progenitor cells (HPCs).

186 ivity of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

187 eting MF hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

188 iferative and survival advantages in the MPN hematopoietic progenitor cells (HPCs).

189 diated human NK differentiation from CD34(+) hematopoietic progenitor cells (HPCs).

190 ation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs).

191 n cytomegalovirus (HCMV) resides latently in hematopoietic progenitor cells (HPCs).

192 entiation of hematopoietic stem cells (HSCs)/hematopoietic progenitor cells (HPCs).

193 , we characterized human iPS-derived CD34(+) hematopoietic progenitor cells (HPCs).

194 mportant for the latent infection in CD34(+) hematopoietic progenitor cells (HPCs).

195 transcriptomic profiling of normal human HSC/hematopoietic progenitor cells [HPCs], revealing that se

196 production of large numbers of primary human hematopoietic progenitor cells (HPs) capable of differen

197 ion model to investigate the role of Dot1 in hematopoietic progenitor cell immortalization by MLL fus

198 creased the proportion of JAK2V617F-positive hematopoietic progenitor cells in 6 PV patients studied.

199 eption of erythroid colonies, by maintaining hematopoietic progenitor cells in a state of proliferati

200 ontrol and fine-tune trafficking of HSCs and hematopoietic progenitor cells in embryogenesis and duri

201 They possessed an increased number of hematopoietic progenitor cells in peripheral blood, sple

202 n; and a 2-fold increase in the frequency of hematopoietic progenitor cells in peripheral blood.

203 e proportion of phenotypic HSCs and immature hematopoietic progenitor cells in phase G0 of the cell c

204 tly used to stimulate bone marrow release of hematopoietic progenitor cells in preparation for stem c

205 s involved in synergistic growth of immature hematopoietic progenitor cells in response to SCF plus G

206 ase in circulating levels of mesenchymal and hematopoietic progenitor cells in ROSI-treated animals.

207 ges of transduced peripheral blood cells and hematopoietic progenitor cells in the bone marrow.

208 hich a low ROS level is required to maintain hematopoietic progenitor cells in the tissue and to redu

209 Identification of hematopoietic progenitor cells in the zebrafish (Danio r

210 d erythroid differentiation of primary human hematopoietic progenitor cells in vitro in the absence o

211 lpha(5)beta(2)-integrin-mediated adhesion of hematopoietic progenitor cells in vitro.

212 es expansion of hematopoietic stem cells and hematopoietic progenitor cells in vivo and ex vivo when

213 y, whereas overexpression of Brn3a in murine hematopoietic progenitor cells induces terminal myeloid

214 ablish and/or maintain a latent infection in hematopoietic progenitor cells infected in vitro.

215 presence of mainly alphabeta integrin in all hematopoietic progenitor cells interacting with splenic

216 ystem components by transplantation of human hematopoietic progenitor cells into NOD-scid IL2Rgamma(n

217 Spi-B is crucial for the differentiation of hematopoietic progenitor cells into pDCs by controlling

218 for E-selectin binding and for migration of hematopoietic progenitor cells into the bone marrow.

219 CCR9 controls the immigration of multipotent hematopoietic progenitor cells into the thymus to sustai

220 skewing promote oncogenic transformation of hematopoietic progenitor cells into therapy-resistant le

221 Moreover, elevated ROS production by hematopoietic progenitor cells is also regulated by S1P.

222 Thy-1, a marker of hematopoietic progenitor cells, is also expressed in act

223 aMKIV) is present in c-Kit+ ScaI+ Lin(-/low) hematopoietic progenitor cells (KLS cells) and that its

224 We found that RPS19 deficiency in hematopoietic progenitor cells leads to decreased GATA1

225 onstitutively overexpressed in the primitive hematopoietic progenitor cell line EML.

226 by which that occurs, using an immortalized hematopoietic progenitor cell line, EML-C1, as a model s

227 crophage differentiation of a multipotential hematopoietic progenitor cell line.

228 igratory responses of cocultured stromal and hematopoietic progenitor cell lines, helping explain how

229 including induced intracellular signaling in hematopoietic progenitor cells, lymphocytes, other innat

230 factor (VEGF), VEGF receptor, and CD34/CD31 (hematopoietic progenitor cell marker/endothelial cell ma

231 In the mouse embryo, hematopoietic progenitor cells migrate to the fetal live

232 Two hematopoietic progenitor cell miR, miR-10 and miR-126, a

233 ts receptor, CXCR4, are essential for normal hematopoietic progenitor cell movement and adherence wit

234 Thus, Id1 is required for regulating the hematopoietic progenitor cell niche but is dispensable f

235 quantification of circulating EPC number and hematopoietic progenitor cell number and for analysis of

236 Sunitinib diminished hematopoietic progenitor cell numbers, and sunitinib enh

237 cells, we transduced lineage-depleted murine hematopoietic progenitor cells, observing GFP expression

238 Interestingly, the hematopoietic progenitor cells of C/EBPbeta-deficient mi

239 lacked the N-terminal DNA-binding domain in hematopoietic progenitor cells of reconstituted mice.

240 Using adult hematopoietic progenitor cells our system demonstrated t

241 Hematopoietic progenitor cells overexpressing Id2 did no

242 Murine hematopoietic progenitor cells overexpressing MPP1 acqui

243 ability in hematopoietic stem cell (HSC) and hematopoietic progenitor cell populations from young and

244 Somatic mutations were tracked to CD34(+) hematopoietic progenitor cell populations, being further

245 5azaD/TSA treatment, JAK2V617F-negative PMF hematopoietic progenitor cells preferentially homed to t

246 lation and the expression of PML-RARalpha in hematopoietic progenitor cells prevented differentiation

247 ients with systemic histiocytoses resides in hematopoietic progenitor cells prior to committed monocy

248 ation of ERK in these cells led to rescue of hematopoietic progenitor cell proliferation in vitro and

249 Knock-down of Id2 by shRNA in hematopoietic progenitor cells promoted B-cell different

250 ug sensitivity, and abrogated MPP1-dependent hematopoietic progenitor cell replating in methylcellulo

251 e that myeloid lineage identity of malignant hematopoietic progenitor cells requires the residual exp

252 asia, fibrosis, and impaired colonization by hematopoietic progenitor cells, resulting in anemia and

253 metry analysis of MDSCs generated from mouse hematopoietic progenitor cells revealed that the CD11b(+

254 dicate that iPAR/6TG can be used for in vivo hematopoietic progenitor cell selection.

255 of T-lineage specification in human CD34(+) hematopoietic progenitor cells, similar to ICN1 overexpr

256 high-dose chemotherapy (HDC) with autologous hematopoietic progenitor cell support (AHPCS) with a mod

257 ptor tyrosine kinase with important roles in hematopoietic progenitor cell survival and proliferation

258 , Gimap5 is an important stabilizer of mouse hematopoietic progenitor cell survival.

259 ells are a novel source of cells, especially hematopoietic progenitor cells that can be used to treat

260 shown to more efficiently differentiate into hematopoietic progenitor cells that engrafted in allogen

261 etic development, and found defects in early hematopoietic progenitor cells that were propagated thro

262 Conversely, in hematopoietic progenitor cells, the inhibition of miR-9

263 Although both ligands activated Notch in hematopoietic progenitor cells, they had an opposite eff

264 In vitro exposure of human or murine hematopoietic progenitor cells to 10 mum ABA does not in

265 elogenous leukemia (CML) caused normal mouse hematopoietic progenitor cells to divide more readily, a

266 ator during differentiation from multipotent hematopoietic progenitor cells to erythroid cells.

267 The expressed EPO protein stimulated hematopoietic progenitor cells to form significant numbe

268 Mechanistically, 1,25(OH)2D3 drives hematopoietic progenitor cells to rapidly upregulate mon

269 ted the capacity of human CB-derived CD34(+) hematopoietic progenitor cells to regenerate injured alv

270 used gamma-irradiated primary human CD34(+) hematopoietic progenitor cells to show that 5-AED protec

271 ged mice correlated with reduced adhesion of hematopoietic progenitor cells to stroma and with elevat

272 apillary level that enhances the recruitment hematopoietic progenitor cells to the site.

273 t al. demonstrate that TLR signals also bias hematopoietic progenitor cells toward myelopoiesis direc

274 er therapy, an autologous transplantation of hematopoietic progenitor cells transduced ex vivo with a

275 Primary murine hematopoietic progenitor cells transduced with Cdx2 acqu

276 ished in immune-compromised mice after human hematopoietic progenitor cell transfer.

277 of high-risk adenovirus infections following hematopoietic progenitor cell transplantation prior to,

278 s of thrombotic microangiopathy secondary to hematopoietic progenitor cell transplantation, infection

279 tify novel intermediate stages through which hematopoietic progenitor cells travel.

280 romote AML, we coexpressed both mutations in hematopoietic progenitor cells used to reconstitute leth

281 Also, hematopoietic progenitor cells utilize the RB pathway to

282 rvival-enhancing effects on irradiated human hematopoietic progenitor cells via induction, stabilizat

283 The peripheral blood content in hematopoietic progenitor cells was analyzed.

284 The survival defect of hematopoietic progenitor cells was cell intrinsic, as tr

285 ably, sustained expression of EBF in Pax5-/- hematopoietic progenitor cells was sufficient to block t

286 d increase in marrow Lin(-)Sca-1(+)c-Kit(+) (hematopoietic progenitor) cells was blunted in mutant mi

287 t-like or a replicative infection in CD34(+) hematopoietic progenitor cells, we defined classes of lo

288 ssion and ex vivo differentiation of CD34(+) hematopoietic progenitor cells, we demonstrate that C/EB

289 Using purified normal human early hematopoietic progenitor cells, we find that AML1-ETO im

290 To enable more precise analyses of hematopoietic progenitor cells, we have created zebrafis

291 rect target genes of HOXB4 in primary murine hematopoietic progenitor cells, we induced HOXB4 functio

292 Hematopoietic progenitor cells were also significantly i

293 of survival and replating capacity of human hematopoietic progenitor cells were observed with CXCL12

294 (FL) contained normal numbers of functional hematopoietic progenitor cells, were radioprotective, an

295 o significant effect up to 1000 nM on normal hematopoietic progenitor cells, whereas in AML patient s

296 l pathway activated by BCR-ABL expression in hematopoietic progenitor cells, which promotes oncogenic

297 ly suppresses the growth and expansion of PV hematopoietic progenitor cells while having little effec

298 y glycosyltransferases, and decorates marrow hematopoietic progenitor cells with alpha2,6-linked sial

299 lantation, the successful transplantation of hematopoietic progenitor cells with the development of m

300 f a human cell AML, generated in CD34+ human hematopoietic progenitor cells xenografted into immunoco